Supreme Court Rules Against 'pay-to-delay'

Source: PharmaManufacturing.com

Jun 18, 2013

Economic Times

U.S. pharmaceutical companies can now be sued for forging deals to keep the cost of drugs high to delay the creation of generic and less expensive drugs. These deals are known as 'pay-to-delay' arrangments and the Supreme Court ruled them "presumptively unlawful", though they did not go so far as to call the practice illegal. Justices said litigants could still challenge deals individually on a case-by-case basis. Read the full story.
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments